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Abstract: The main aim of this study was to assess the efficacy of 
Therabite® compared to current standard treatment using wooden spatulas 
in relieving or preventing trismus.   Secondary aims were to assess the 
feasibility and the impact of proactive exercise on health-related 
quality of life and post-treatment clinical management/health care 
utilisation. 
Materials and Methods.  Randomised, open-label, controlled, three-centre 
feasibility study, to assess the effectiveness and cost-effectiveness of 
Therabite use compared with wooden spatula in ameliorating trismus in 
patients treated for stage 3 and 4 oral and oropharyngeal cancer treated 
with radiotherapy.  Compliance with exercises and health-related quality 
of life were examined and 3 health economics measures were assessed. 
Results.  37 patients were randomised to receive the Therabite device and 
34 the wooden spatulas for jaw exercises.  All patients had some sense of 
jaw tightening prior to study entry.   Mean mouth opening after 6months 
increased in both groups following the exercise intervention, with non-
significant differences between the two arms (p=0.39).  Completion rates 
of the 3 health economic measures were good.  There was no significant 
difference between the two groups in frequency of contact with care 
services nor in quality of life .      
Conclusions.  Proactive exercises during and after radiotherapy can 
ameliorate trismus for stage 3 and 4 oral, oropharygeal cancers ,but we 
found no statistically significant difference between use of Therabite 
and wooden spatulas (control) in efficacy, compliance, quality of life or 
hospital/community health services utilisation.   
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Dear Editor, 
 
Please find enclosed this article which we would be grateful for consideration of 
publication in BJOMS. We feel this to be the most appropriate journal as it is a cross 
disciplinary scientific medical journal which is read widely by the whole MDT. 
We feel this paper will be of interest to your readers as we have established that 
prophylactic exercises can ameliorate post radiotherapy trismus, that the trismus exercise 
regime needs to be flexible to improve compliance and that the use of  health economics 
questionnaires are feasible in the context of further trials.  We still don’t know if there is 
any therapeutic advantage to using Therabite over wooden spatulas and would advocate a 
larger national trial to resolve this; the learning from this study would greatly facilitate 
successful recruitment and compliance in a larger trial. 
We look forward to your comments. 
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Table 1:  Baseline characteristics 
 Wooden spatulas Therabite 
Centre 
  Liverpool 
  Birmingham 
  Manchester 
 
10 
 1 
23 
 
12 
 3 
22 
Surgery 
  No 
  Yes 
 
14  
20  
 
11  
26  
Chemoradiation 
  No 
  Yes 
 
 9  
25  
 
14  
23 
Gender 
  Male 
  Female 
 
24 
10 
 
25 
12 
Alcohol use 
  Current heavy 
  Previous heavy 
  Never heavy 
 
 4 
 8 
22 
 
 2 
16 
19 
Smoking status 
  Current smoker 
  Ex smoker 
  Never smoked 
 
 4 
17 
13 
 
 4 
25 
 8 
Site of disease 
  Oral 
  Oropharyngeal 
 
11 
23 
 
15 
22 
Stage   
  T1/2 N+ M0 
  T3/4 N0 M0 
  T3/4 N+ M0 
14 
 5 
15 
16 
 4 
17 
 
Table 1
Table 3:  Frequency of contacts with primary and secondary care health services use by 30 
participants in the Trismus feasibility trial at 6 month post-baseline 
 
 
Therabite 
(n = 16) 
Total; Mean, 
median (min, max) 
Wooden spatulas 
(n = 14) 
Total; Mean, median 
(min, max) 
Mann 
Whitney 
p-value1 
NHS Primary Care Sector: 
Cancer nurse 10; 0.63, 0 (0, 4) 6; 0.43, 0 (0, 6) 0.313 
General practitioner 51; 3.19, 2 (0, 13) 32; 2.29, 2 (0, 5) 0.697 
Practice nurse 25; 1.56, 0 (0, 14) 7; 0.50, 0 (0, 3) 0.637 
Community nurse 128; 8.00, 1 (0, 56) 47; 3.36, 1 (0, 22) 0.667 
Physiotherapist 2; 0.13, 0 (0, 2) 18; 1.29, 0 (0, 9) 0.294 
Speech and language 
therapist 43; 2.69, 2 (0, 14) 36; 2.57, 2 (0, 9) 
1.000 
Occupational health 
therapist 0; 0.00, 0 (0, 0) 0; 0.00, 0 (0, 0) 
1.000 
Dietician 41; 2.56, 1 (0, 16) 51; 3.64, 2 (0, 11) 0.637 
Other healthcare 
professional 81; 5.06, 1 (0, 52) 28; 2.00, 1 (0, 10) 
0.667 
NHS Secondary Care Sector: 
Oncology inpatient ward 
(bed days) 
256; 16.06, 9 (0, 78) 217; 15.50, 6 (0, 74) 0.790 
Medical inpatient ward 
(bed days) 
31; 1.94, 0 (0, 14) 51; 3.64, 0 (0, 30) 0.854 
Intensive care inpatient 
ward 
(bed days) 
0; 0.00, 0 (0, 0) 0; 0.00, 0 (0, 0) 1.000 
Other inpatient ward 
(bed days) 
6; 0.38, 0 (0, 6) 0; 0.00, 0 (0, 0) 0.790 
Physiotherapist inpatient 
consultation 62; 3.88, 0 (0, 55) 3; 0.21, 0 (0, 2) 
1.000 
Speech and language 
therapist inpatient 
4; 0.25, 0 (0, 2) 4; 0.29, 0 (0, 2) 0.918 
Table 3
consultation 
Dietician inpatient 
consultation 56; 3.50, 1 (0, 25) 38; 2.71, 1 (0, 20) 
0.822 
Occupational health 
therapist inpatient 
consultation 
2; 0.13, 0 (0, 2) 0; 0.00, 0 (0, 0) 0.790 
Other inpatient consultation 3; 0.19, 0 (0, 2) 0; 0.00, 0 (0, 0) 0.580 
Outpatient visits 76; 4.75, 1 (0, 30) 74; 5.29, 1 (0, 58) 1.000 
Accident and emergency 1; 0.06, 0 (0, 1) 18; 1.29, 0 (0, 12) 0.154 
1 = significant at 5% significance level 
 
Table 4: Mean costs of all contacts with NHS primary and secondary care services use by 30 participants in 
the Trismus trial (£) over the six-month follow-up period 
 
 
Therabite (n=16) 
Mean  (SD) in £ 
Wooden spatulas 
(n=14) 
Mean (SD) in £
 
Mean difference in £ 
(95% CI bootstrapped) 
    
NHS Primary Care    
Cancer nurse 
60.47 (139.12) 38.57 (144.32) 
21.90 
General practitioner 
188.91 (210.35) 190.82 (194.58) 
-1.91 
Practice nurse 
18.22 (34.96) 11.99 (26.24) 
6.23 
Community nurse 
307.66 (704.63) 113.14 (223.99) 
194.52 
Physiotherapist 
4.50 (18.00) 27.85 (56.46) 
-23.35 
Speech and language therapist 
45.56 (47.64) 46.93 (48.14) 
-1.37 
Occupational health therapist 
0.00 (0.00) 0.00 (0.00) 
0.00 
Dietician 
37.77 (49.38) 95.58 (122.89) 
-57.81 
Other healthcare professional 
172.48 (316.27) 135.57 (246.80) 
36.91 
Total NHS primary care costs 835.56 
(974.13) 
660.46 
(637.13) 
175.10 
(-358.51 to 759.77) 
NHS Secondary Care   
 
Oncology inpatient ward 
9678.00 (12783.29) 9001.93 (12641.66) 
676.07 
Medical inpatient ward 
1110.19 (2532.19) 2087.36 (4797.26) 
-977.17 
Intensive care inpatient ward 
0.00 (0.00) 0.00 (0.00) 
0.00 
Other inpatient ward 
120.75 (483.00) 0.00 (0.00) 
120.75 
Physiotherapist inpatient 
consultation 164.00 (579.91) 10.43 (27.76) 
153.57 
Speech and language therapist 
inpatient consultation 24.13 (54.54) 27.57 (57.71) 
-3.44 
Dietician inpatient consultation 
216.19 (388.57) 169.14 (316.15) 
47.05 
Occupational health therapist 
inpatient consultation 8.50 (34.00) 0.00 (0.00) 
8.50 
Other inpatient consultation 
16.94 (48.06) 0.00 (0.00) 
16.94 
Outpatient visits 
513.56 (1000.97) 466.29 (1205.24) 
47.27 
Table 4
Accident and emergency 
6.56 (26.23) 134.88 (332.85) 
-128.32 
Total NHS secondary care costs 11858.81 
(14055.02) 
11897.60 
(13421.63) 
-38.79 
(-9463.46 to 9446.84) 
Total NHS primary and 
secondary care costs 
12694.37 
(14136.93) 
12558.06 
(13675.36) 
136.31 
(-9419.24 to 9791.03) 
Intervention cost (Intervention – 
‘Therabite’ and Control – ‘Wooden 
spatula’) 
251.94 (0.00) 2.84 (0.00) 249.10 
Total cost 
12946.31 
(14136.93) 
12560.90 
(13675.36) 
385.41 
(-8916.37 to 10013.82) 
NHS: National Health Service 
 
 
Table 5 : Mean EQ-5D-3L index scores, mean QALYs and incremental mean QALYs at 6 months post-baseline by group (n=30) 
 
 Therabite (n = 16) 
Mean (SD) 
Wooden spatulas (n = 14) 
Mean (SD) 
 Incremental mean QALYs 
between groups® 
(bootstrapped 95% CI) 
Measure Baseline 3 
months 
6 
months 
QALY 
over 6 
months 
Baseline 3 
months 
6 
months 
QALY 
over 6 
months 
EQ-5D-3L index 0.6914 
(0.1863) 
0.6209 
(0.2806) 
0.6935 
(0.2523) 
0.3283 
(0.1082) 
0.6232 
(0.3599) 
0.6824 
(0.2999) 
0.7481 
(0.1844) 
0.3420 
(0.1330) 
-0.0137 
(-0.0978 to 0.0706) 
® Incremental mean QALYs between groups=mean QALYs for intervention group minus mean QALYs for control group 
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Table 6: Mean ICECAP-A capability index scores, change in mean ICECAP-A index score between study time points and difference in mean 
change scores between groups at 6 months post-baseline by group (n=19<30)∞ 
 
 Therabite (n = 8) ∞ 
Mean (SD) 
Wooden spatulas (n = 11) ∞ 
Mean (SD) 
 Difference in mean change 
scores between groups¥ 
(bootstrapped 95% CI) 
Measure Baseline 3 
months 
6 
months 
Change 
in mean 
ICECAP-
A index 
score 
between 
baseline 
and 6 
months 
Baseline 3 
months 
6 
months 
Change 
in mean 
ICECAP-
A index 
score 
between 
baseline 
and 6 
months 
ICECAP-A 
capability index 
scores 
0.8733 
(0.1092) 
0.8095 
(0.1967) 
0.8551 
(0.1209) 
-0.0182 
(0.0873) 
0.8914 
(0.1524) 
0.9175 
(0.0927) 
0.9079 
(0.1506) 
0.0165 
(0.2029) 
-0.0347 
(-0.1726 to 0.0828) 
¥ Difference in mean change scores between groups = (Mean change score for intervention) minus (Mean change score for control) 
∞ ICECAP-A analysis was conducted on 19 out of 30 participants who had complete ICECAP-A data (n=8 Therabite group, n=11 wooden 
spatulas group). 
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A Randomised Feasibility Study of Therabite versus Wooden Spatula in the Amelioration of 
Trismus in Head and Neck Cancer Patients. 
Dear Editor,  please find enclosed actioned, reviewers comments including stats comments. 
 
Reviewer 1 
Actions:  
Maximum mouth opening measurements  
Six month mouth opening measurements were supplied by 41/71 participants. These 
tentatively indicate that mouth opening in both groups had not deteriorated following the 
exercise intervention.  There was no statistically significant difference between the two 
interventions though the power of the study was low due to failing to achieve the target 
recruitment and a higher than anticipated attrition rate. The estimated difference in average 6 
month mouth opening (Wooden spatula versus Therabite) after adjustment for baseline, 
centre, surgery and chemoradiation in an analysis of covariance model was 2.43mm with 
95% CI (-8.15 to 3.29).  This is not a statistically significant difference (p=0.39).  
Exercise compliance rates were poor particularly at the end of radiotherapy but not markedly 
different between the two trial arms; this data was obtained from the patients logs. 
Reviewer 2 
Actions: 
Limitations of the study: 
Pre- radiotherapy patients who indicated subjective tightening of the jaw were included in the 
study, omitting those patients who, during radiotherapy may have developed tightening of the 
jaw.  This could be captured by a more adaptive study design such as a stepped wedge design 
whereby patients are randomised as soon as jaw tightening develops.   
*Response to Reviewers
A larger group of patients and more study specific follow up may also have provided greater 
representative data on both the quantitative and qualitative aspects of the study.  A larger 
telephone interview pool of patients may also have provided richer insight to day to day 
living with trismus.  Patients’ suggestions of rewording the exercise regime to ‘up to 5 times 
a day’, when exercises were more likely to be performed 3 times a day have not been 
validated to test for frequency effects.  The dose-effect analysis of a new therapy protocol  
would be required in future studies. 
The attrition rate for this study was set at 25% which is in agreement with other head and 
neck cancer toxicity intervention studies, but was higher in this study than expected. The 
likely explanations include the demands of the prescribed exercise regimen as well as the 
difficulty in compliance in the presence of severe mucositis. 
It would be useful to employ a more sensitive scale to measure trismus-specific symptoms, 
such as the Gothenburg Trismus Questionnaire (which was not available at the start of our 
trial), for a full scale trial as it can be used to track changes in trismus specific symptoms 
[25].  
All stats comments have been actioned and shown in red on the submitted manuscript.  
A Randomised Feasibility Study of Therabite versus Wooden Spatula in 
the Amelioration of Trismus in Head and Neck Cancer Patients 
 
 
Abstract 
The main aim of this study was to assess the efficacy of Therabite® compared to current 
standard treatment using wooden spatulas in relieving or preventing trismus.   Secondary 
aims were to assess the feasibility and the impact of proactive exercise on health-related 
quality of life and post-treatment clinical management/health care utilisation. 
Materials and Methods.  Randomised, open-label, controlled, three-centre feasibility study, 
to assess the effectiveness and cost-effectiveness of Therabite use compared with wooden 
spatula in ameliorating trismus in patients treated for stage 3 and 4 oral and oropharyngeal 
cancer treated with radiotherapy.  Compliance with exercises and health-related quality of life 
were examined and 3 health economics measures were assessed. Semi-structured patient 
interviews were also conducted.  
Results.  37 patients were randomised to receive the Therabite device and 34 the wooden 
spatulas for jaw exercises.  All patients had some sense of jaw tightening prior to study 
entry.   Mean mouth opening after 6 months increased in both groups following the exercise 
intervention, with non-significant differences between the two arms (p=0.39).  Completion 
rates of the 3 health economic measures were good.  There was no significant difference 
between the two groups in frequency of contact with care services nor in quality of life.   
Conclusions.  Proactive exercises during and after radiotherapy can ameliorate trismus for 
stage 3 and 4 oral, oropharygeal cancers, but we found no statistically significant difference 
between use of Therabite and wooden spatulas (control) in efficacy, compliance, quality of 
life or hospital/community health services utilisation.   
*Manuscript with title (excluding any author details including names and affiliations)
Click here to view linked References
Keywords: Trismus; Head and Neck cancer; Randomised trial; Feasibility; Health 
economics; Exercises 
 
Introduction 
Around 7,600 patients were diagnosed with lip, oral cavity and oropharynx cancer in the UK 
in 2013 (CRUK 2013).  Standard treatments for these patients involve a variable combination 
of surgery, radiotherapy and chemotherapy. Patients can develop trismus, a condition 
affecting the jaw muscles and making mouth opening difficult, from their disease or 
treatment. Trismus is underreported as a significant deleterious impact from treatment [1] 
with radiotherapy being been reported as one of the most frequent causes of this condition. 
Dijkstra’s (2006) definition of trismus as a maximum mouth opening of 35mm or less is now 
widely accepted [2].  Trismus can impair chewing, swallowing, speaking, oral health, dental 
integrity and overall quality of life [3,4,5,6].  Psychological difficulties can include low self-
esteem, depression and suicidal tendencies [7].         
 
Previously published work by Van der Molen and Carnaby-Mann in the area of proactive jaw 
exercises for head and neck patients receiving chemoradiotherapy have shown less of  a 
decline in mouth opening compared to standard post treatment rehabilitation techniques; 
however both studies had small numbers, only 10 week follow up and no economic 
evaluations [8, 9].  Current standard post- treatment interventions such as wooden spatulas, 
Therabite, Dynasplint and swallowing therapies have only shown a modest effect once 
trismus is established [10,11,12,13,14].  A recent systematic review alternatively suggested 
that jaw exercise therapy can have a positive impact on mouth opening in established 
radiotherapy-induced trismus [12].  In view of these conflicting opinions, there is consensus 
on  the need for a rigorous, controlled study to provide clearer evidence regarding the value 
of  proactive exercise devices in patients with  pre-radiotherapy trismus or at high risk of 
developing radiotherapy-induced trismus [10]. 
 
This was a feasibility study to establish whether there is an indication of benefit to proactive 
exercises and to inform the design of a future larger study, in line with the MRC Framework 
for complex interventions [15].  
 
The main aim was to assess the efficacy of Therabite® as compared with current standard 
treatment using wooden spatulas in relieving or preventing trismus.   
 
Secondary aims were to assess the feasibility and the impact of proactive exercise on health-
related quality of life, post-treatment clinical management and healthcare resource use along 
with completion rates of the health economic outcome measures (CSRI, EQ-5D-3L and 
ICECAP-A).  
 
Materials and Methods 
This was a randomised, open-label  controlled, three-centre feasibility study comparing 
Therabite  with wooden spatulas in ameliorating trismus in patients treated for stage 3 and 4 
oral and oropharyngeal cancer.  The study was approved by the North Manchester Ethics 
committee (12/NW/0414) and all patients gave written informed consent prior to study 
commencement. 
 
Patients & Settings 
Patients with stage 3 and 4 oral and oropharyngeal cancer managed either by primary 
(chemo)radiotherapy or surgery followed by (chemo)radiotherapy were recruited from three 
tertiary referral centres in England.  Patients who self reported a sense of jaw tightening prior 
to radiotherapy were offered  study entry.  All patients were prescribed a dose of  60-70 Gy in 
30-35 fractions over 6 to 7 weeks using IMRT to the region of the jaw muscles.  
 
To detect a minimum of 5mm  difference in mean change from the baseline mouth opening 
level, with a common standard deviation  of 8mm (previously estimated from patients that 
have had no intervention and have had radiotherapy) with 80% power  required 42 cases per 
group.  With a predicted 25% attrition rate, 112 patients  were required in total.  
 
Randomisation was performed using the minimistion method with a random element 
(allocation was with probability 0.75 to the arm yielding a lower imbalance score or 0.5 if 
scores were tied) .   Factors controlled for were: surgery or no surgery, centre and 
synchronous chemotherapy given or not given.   
 
After patients had been randomly assigned to receive wooden spatulas or Therabite they were 
instructed to perform their mouth exercises according to a set protocol.  
 
Patients were excluded if mouth opening was <12mm (cannot fit Therabite), were 
anatomically unable to use Therabite due to being partially dentate  and patients who had a 
past history of previous surgery or radiotherapy to the head and neck.  
 
Therabite/Wooden Spatula Protocol and measurement of Mouth Opening. 
Patients randomised to either wooden spatula or Therabite use were asked to follow the 5-5-
30 protocol which comprised  5 sessions per day for 6 months, with 5 opening/closing per 
session, each opening for a 30 second stretch [16, 17].  Patients commenced Therabite or 
spatula use approximately 3 weeks post surgery and /or 1-3 weeks pre radiotherapy.  Patients 
recorded the maximum mouth opening at the end of each day using a Platon Therabite 
motion scale and documented the readings on a log, to capture compliance to exercises.  
Additional readings from the bottom of the nose to the chin with the mouth closed and open 
were also taken using a Willis bite calliper at baseline and again at 3 and 6 months post 
intervention. 
 
Demographic Information 
Baseline patient, tumour and treatment characteristics are documented in Table 1.  
 
Quality of Life. 
Quality of Life (QoL) assessments were preformed at baseline, 3 and 6 months post 
intervention.  QoL was assessed using the European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C 30) and Head and Neck 
(H&N) module (EORTC QLQ H&N 35) [18].  Data was collected using QoLproforma 
sheets.   
 
Health Economics Assessments:  
The following assessments were used: 
EQ-5D-3L (European Quality of Life-5 Dimensions-3 Levels) (baseline, 3, 6 months) -  This 
is a validated generic, health-related, preference-based measure [19], comprising five 
domains: mobility; self-care; usual activities; pain and discomfort; anxiety and depression. 
Each domains has three levels: no problem, some problems and major problems, thus giving 
a total of 243 possible health states [20] . The reported health-related quality of life states 
were converted into EQ-5D-3L index a single utility scores anchored at 0 for death and 1 for 
perfect health. Negative score is also possible when patient values their health worse than 
death [21,20].  The EQ-5D-3L index scores were then translated into quality-adjusted life 
years (QALYs) by weighting them with quantity of life (the aggregated number of years 
lived), using the area-under-the-curve method [22, 23]. QALYs a common unit of effect is a 
measure of utility, which has been advocated by the National Institute for Health and Care 
Excellence (NICE) in the UK for the evaluation of cost-effectiveness [24].  
 
ICECAP-A (ICEpop CAPability measure for Adults) (baseline, 3, 6 months) This is a more 
encompassing quality of life measure [25].  There are 5 domains: attachment, security, role, 
enjoyment and independence.  
  
CSRI - A Client Service Receipt Inventory [26].  Patients’ contacts with primary and 
secondary care services were collected retrospectively at 3 and 6 months by interview. This 
included their contacts with services such as speech and language therapy, dietary and 
nutritional advice and/or artificial feeding and orthodontic interventions including surgery.   
 
Nested qualitative study 
Semi-structured telephone interviews were conducted up to 6 months post study completion 
to explore the experience of the patient taking part in the study and their experience of daily 
living with trismus.  Items discussed included compliance with the protocol and whether pain 
had affected their compliance with the intervention so as to consider such variables in a 
future phase III trial.  Data was transcribed verbatim; data analysis was conducted using the 
framework analysis reported by Richie and Spencer [27]. 
 
Data analysis  
Analysis was undertaken using Stata (version 13) SPSS (version 16).  The null hypothesis for 
the primary analysis was that there is no difference in the amount of mouth opening at six 
months between the two arms of the trial.   
 
Descriptive statistics were used to identify prevalence of trismus between the two groups and 
their respective mouth openings.  Similarly descriptive statistics were used to calculate the 
number of patients completing different parts of the study and the amount of missing data.   
 
 
The original power calculation was based on a t-test of change scores but a more efficient 
analysis method is analysis of covariance (ANCOVA). An ANCOVA model was fitted with 
the six month mouth opening measurement as the reponse and the trial arm as the variable of 
primary interest after adjustment for baseline, centre, surgery and chemo-radiation. 
 
 
Economic analysis was undertaken using Microsoft Excel 2013 and SPSS (IBM SPSS 
Statistics 22). Confidence intervals (CIs) for costs and health-related quality of life were 
estimated using non-parametric boostrapping methods [28, 29]. A simulation of 5000 non-
parametric bootstrapping iterations were run to construct 95% CIs around estimates of costs 
and quality of life scores using Microsoft Excel 2013. 
Results 
Seventy one of 237 patients screened in three UK centres were randomised to the study.  
Main reasons for screening failure included no subjective tightening of the jaw or declined 
participation.   
 
Thirty-seven patients were allocated to the Therabite intervention and 34 received Wooden 
spatulas (Table 2 CONSORT diagram).  Median baseline maximum mouth opening readings 
were 24.0mm (range 12.0-58.0), for the Therabite group and 21.8mm (range 12.5–48.0) for 
the wooden spatula group.  Recorded baseline characteristics (age, gender, prior surgery, 
(chemo)radiation, disease site, disease stage, alcohol use and smoking status)  were broadly 
similar between the two intervention groups.  This was made possible by using the priori 
stratification factors to minimise differences at baseline (Table 1 Baseline Characteristics).  
 
Maximum mouth opening measurements  
Six month mouth opening measurements were supplied by 41/71 participants. These 
tentatively indicate that mouth opening in both groups had not deteriorated following the 
exercise intervention.  There was no statistically significant difference between the two 
interventions though the power of the study was low due to failing to achieve the target 
recruitment and a higher than anticipated attrition rate. The estimated difference in average 6 
month mouth opening (Therabite versus Wooden spatula) after adjustment for baseline, 
centre, surgery and chemoradiation in an analysis of covariance model was -2.43 mm with 
95% CI (-8.15 to 3.29).  This is not a statistically significant difference (t35 = -0.86 , 2-tail p = 
0.39).  There was no formal evidence against two key assumptions of the fitted model: 
Normality of the residuals (Shapiro-Wilk W test, Z = 0.6 , 1-tail p = 0.27) and homogeneity 
of the variance (Cook-Weisberg test for heteroskedasticity, X5
2
 = 7.90, 1-tail p = 0.16) 
Exercise compliance rates were poor particularly at the end of radiotherapy but not markedly 
different between the two trial arms; this data was obtained from the patients logs. 
 
Health related quality of life 
Subscales (taken from the EORTC QLC-C30) around ‘eating’, ‘weight loss’, ‘pain’, and 
‘mouth opening’ were predicted to be more sensitive to changes than others in trismus 
patients.  However, there was no marked difference in the observed mean change scores from 
baseline to 6 months between the wooden spatula and Therabite groups for any of these 
items.  
 
Telephone interviews:  The consequences and possible effects of the exercises on pain and 
compliance with the exercise protocol were explored as well as the nature, acceptability and 
impact of the exercises in terms of motivation and perceived gain in maximum mouth 
opening.  From the 15 telephone interview participants there was a mix of compliant and non-
compliant participants at both 3 and 6 month follow up periods. The trend seemed to be 
greater compliance in the Therabite group at both 3 and 6 months. Patients felt they had to 
stop or reduce exercises towards the end of the course of radiotherapy until approximately 4 
weeks post radiotherapy due to painful mucositis.  Exercises were then restarted when side 
effects had abated. 
 
Key feasibility and acceptability messages were:  change the wording of the exercise regimen 
to at ‘least 3 times a day’ rather than 5 times a day; have a scheduled break from the exercises 
when radiotherapy side effects are at their worst; more regular contact with healthcare 
professionals is needed.   
Health Economics Assessments:  
Completion rates of the three health economics measures (CSRI, EQ-5D-3L and ICECAP-A) 
were evaluated: CSRI had completion rates of 89% and 100% at 3 and 6 months respectively; 
EQ-5D-3L had 90% at baseline, 78% at 3 months and 87% at 6 months; ICECAP-A had 
59%, 49% and 74% at baseline, 3 and 6 months respectively. Across the study time-points, 
completion rates for CSRI, EQ-5D-3L and ICECAP-A were overall, on average, 95%, 85% 
and 61% respectively. 
 
In addition, although not a core feasibility objective, an exploratory cost consequences 
analysis was conducted on the participants that had complete cost and outcome data (n=30). 
The exploratory cost consequences analysis was undertaken from an NHS perspective, the 
results are presented in Table 3, 4, 5 and 6. 
 
Table 3 shows frequency of contacts with primary and secondary care health services at 6 
month post-baseline. Results show that there is no significant difference between the two 
groups in the frequency of contacts with primary and secondary care services. 
 
Table 4 shows mean costs of all contacts with NHS primary and secondary care services use 
by participants in the Therabite and wooden spatulas groups over the six-month follow-up 
period.  The Therabite intervention cost £251.94 per patient as compared with £2.84 for 
patients receiving wooden spatulas.  Taking account of the cost of Therabite intervention and 
wooden spatulas, the mean total cost per patient was £12,946 (SD £14,137) in the Therabite 
group and £12,561 (SD £13,675) in the wooden spatulas group.  This shows that the 
Therabite group costs £385 (bootstrapped 95% CI: -£8,916 to £10,014) higher than the 
wooden spatulas group. 
 
Table 5 shows mean EQ-5D-3L index scores, mean quality-adjusted life years (QALYs) and 
incremental mean QALYs between Therabite and wooden spatulas groups over the six-month 
follow-up period. The mean QALY was 0.3283 (SD 0.1082) for the Therabite intervention 
group and 0.3420 (SD 0.1330) for the wooden spatulas group.  
 Change in mean ICECAP-A index score between study time-points and the difference in 
mean change ICECAP-A index scores between groups over the 6-month study period were 
assessed on the 19 out of the 30 participants who had complete ICECAP-A data.  Table 6 
shows the change in mean ICECAP-A index score between baseline and 6 months for the 
Therabite group was -0.0182 (SD 0.0873) and for the wooden spatulas group was 0.0165 (SD 
0.2029). This yielded a difference of -0.0347 (bootstrapped 95% CI: -0.1726 to 0.0828) 
between groups. 
 
Discussion 
A recent systematic review has shown that post treatment exercise therapy with jaw 
mobilizing devices yields better results than no exercise, in radiotherapy induced trismus in 
head and neck cancer patients [12].  Our study has shown that proactive exercises with 
Therabite or wooden spatulas, prior, during and after radiotherapy treatment can ameliorate 
radiation induced trismus in head and neck cancer patients.  Melchers and colleagues have 
described a positive increase in mouth opening with increased exercise adherence.  This 
group also found that self-discipline and clear setting of objectives are important factors for 
maintaining exercises.  The main factor which negatively affected exercise adherence was 
painful mucositis, as in this study.  Other factors such as anxiety, ill fitting Therabite pads 
and the lack of goal setting during treatment also had a negative effect [30].  Tang et al., also 
showed that rehabilitation training can slow down the progress of trismus in nasopharyngeal 
carcinoma patients after radiotherapy [31].  Several studies which performed exercises after 
radiotherapy have shown that Therabite exercises were no more effective than wooden 
spatulas or active range of motion exercises [32, 33].  Pauli et al have reported that Therabite 
exercises were more effective in increasing mouth opening compared to Engstrom (a wooden 
clothespin with an attached rubber band), although compliance to exercise was comparable 
[34].  An earlier study by Buchbinder showed the Therabite to be more efficient than 
unassisted stretching or stretching using wooden spatulas although this study had small 
numbers of patients [35].   
Limitations of the study: 
Pre- radiotherapy patients who indicated subjective tightening of the jaw were included in the 
study, omitting those patients who, during radiotherapy may have developed tightening of the 
jaw.  This could be captured by a more adaptive study design such as a stepped wedge design 
whereby patients are randomised as soon as jaw tightening develops.   
A larger group of patients and more study specific follow up may also have provided greater 
representative data on both the quantitative and qualitative aspects of the study.  A larger 
telephone interview pool of patients may also have provided richer insight to day to day 
living with trismus.  Patients’ suggestions of rewording the exercise regime to ‘up to 5 times 
a day’, when exercises were more likely to be performed 3 times a day have not been 
validated to test for frequency effects.  The dose-effect analysis of a new therapy protocol  
would be required in future studies. 
The attrition rate for this study was set at 25% which is in agreement with other head and 
neck cancer toxicity intervention studies, but was higher in this study than expected. The 
likely explanations include the demands of the prescribed exercise regimen as well as the 
difficulty in compliance in the presence of severe mucositis. 
It would be useful to employ a more sensitive scale to measure trismus-specific symptoms, 
such as the Gothenburg Trismus Questionnaire (which was not available at the start of our 
trial), for a full scale trial as it can be used to track changes in trismus specific symptoms 
[36].  
This is the first study of its kind to provide both an exercise regimen proactively, pre 
radiotherapy and to include a health economics aspect within the study design to enable 
healthcare professionals to make evidence-based decisions about patient management and 
resource use.  The overall response rates for all the three health economics measures were 
good. In line with a study by Clarke and colleagues, our findings have shown that it is 
feasible to collect health economics information in a definitive randomised trial in this 
population group [37].  
 
Conclusions 
This feasibility study has shown that mouth openings had in fact increased on average in both 
groups following the exercise intervention.  Proactive exercises during and after radiotherapy 
treatment can ameliorate trismus for stage 3 and 4 oral and oropharyngeal cancers.   
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